Skip to main content

and
  1. No Access

    Article

    Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)

    I Nagel, S Bug, H Tönnies, O Ammerpohl, J Richter, I Vater, E Callet-Bauchu in Leukemia (2009)

  2. No Access

    Article

    The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia

    E Chapiro, I Radford-Weiss, C Bastard, I Luquet, C Lefebvre, E Callet-Bauchu in Leukemia (2008)

  3. No Access

    Article

    Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria

    Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an increasing number of publications have dealt with multiple aspects of SMZL diagnosis, molecular pathogenesis and treatment. Th...

    E Matutes, D Oscier, C Montalban, F Berger, E Callet-Bauchu, A Dogan, P Felman in Leukemia (2008)

  4. No Access

    Article

    Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin

    A Traverse-Glehen, A Verney, L Baseggio, P Felman, E Callet-Bauchu in Leukemia (2007)

  5. No Access

    Article

    A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation

    The biologic and pathologic features of B-cell malignancies bearing a translocation t(14;19)(q32;q13) leading to a fusion of IGH and BCL3 are still poorly described. Herein we report the results of a comprehensiv...

    J I Martín-Subero, R Ibbotson, W Klapper, L Michaux, E Callet-Bauchu, F Berger in Leukemia (2007)

  6. No Access

    Article

    Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib

    J M Cayuela, P Rousselot, F Nicolini, D Espinouse, C Ollagnier, M H Bui-Thi in Leukemia (2005)

  7. No Access

    Article

    Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases

    The purpose of this study was to document the frequency and distribution of karyotypic changes present at diagnosis in 103 non-MALT marginal zone cell lymphoma (MZL) patients. This cytogenetic analysis of a la...

    E Callet-Bauchu, L Baseggio, P Felman, A Traverse-Glehen, F Berger, D Morel in Leukemia (2005)

  8. No Access

    Article

    Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis

    C Thieblemont, K Chettab, P Felman, E Callet-Bauchu, A Traverse-Glehen in Leukemia (2002)

  9. No Access

    Article

    Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurrence of dicentric rearrangements and possible association with adverse outcome

    Unbalanced translocations involving chromosome arm 17p, where the TP53 tumor suppressor gene localizes, are rarely described in chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL), but recent...

    E Callet-Bauchu, G Salles, S Gazzo, C Poncet, D Morel, J Pagès, B Coiffier in Leukemia (1999)

  10. No Access

    Article

    Mantle cell lymphoma: a retrospective study of 121 cases

    Mantle cell lymphoma (MCL) patients represent a difficult problem, sometimes to establish the diagnosis but mostly because of their refractoriness to standard lymphoma treatments. Which treatments to apply and...

    H Samaha, C Dumontet, N Ketterer, I Moullet, C Thieblemont, F Bouafia in Leukemia (1998)